Abbott Nutrition has an attractive profile and compelling growth opportunities in large and growing nutrition markets. It has the number one global position in pediatric and adult nutrition and a balanced portfolio across geographies and product categories. Abbott Nutrition aims to strengthen its portfolio with new science-based products, expand its footprint in key emerging markets, grow the adult nutrition segment, and increase operating margins to fund investments in growth.

1. Abbott Nutrition
Attractive Profile and Compelling Growth Opportunities

2. Forward-Looking Statement
Some statements in this presentation may be forward-looking statements for purposes
of the Private Securities Litigation Reform Act of 1995, including the planned separation
of the research-based pharmaceutical company from the diversified medical products
company and the expected financial results of the two companies after the separation.
Abbott cautions that these forward-looking statements are subject to risks and uncertainties
that may cause actual results to differ materially from those indicated in the forward looking
statements, and there is no assurance as to the timing of the planned separation or
whether it will be completed. Economic, competitive, governmental, technological and other
factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors,” to our
Annual Report on Securities and Exchange Commission Form 10-K for the year ended
Dec. 31, 2012 and are incorporated by reference. Except as required by law, Abbott
undertakes no obligation to release publicly any revisions to forward-looking statements as
a result of subsequent events or developments.
Title © 2012 Abbott Laboratories 2
Page 2 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

3. Large and growing markets
Favorable demographics and economics
– Rapidly expanding aging population globally
– High birth rates in emerging markets
– Increasing socio-economic status
in emerging markets
– Growing awareness of the role of nutrition
for health and wellness
Title © 2012 Abbott Laboratories 3
Page 3 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Global Nutrition Market
Abbott Nutrition
Large Markets and Favorable Trends
$36Bn
$52Bn
Sources: Euromonitor, Nielsen, IMS and company estimates.

4. Abbott Nutrition
#1 Nutrition Company Worldwide
Pediatric Nutrition
• #1 in the U.S.
Adult Nutrition
• #1 in the U.S.
• #1 worldwide
Global Nutrition
• #1 or #2 in 25 countries
• 50 consumer brands; 100 countries
#1 based on the adult and pediatric markets in which Abbott competes
Title © 2012 Abbott Laboratories 4
Page 4 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

5. Abbott Nutrition
Unique Balance across Geographies and Portfolio
Geographic Balance Portfolio Balance
45% US
Sales Mix in Full Year 2012
Sales
55% OUS
Title © 2012 Abbott Laboratories 5
Page 5 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Sales
55% Pediatric 45% Adult

6. Abbott Nutrition
Growth Strategies
Strengthen Portfolio
with steady rhythm
of science-based
new products
Expand Footprint
in key high-growth
emerging markets
Grow, shape, and further
penetrate the adult
nutrition market
Expand Operating
Margins to fund
investments in growth
Title © 2012 Abbott Laboratories 6
Page 6 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

7. Abbott Nutrition
Growth Strategies
Strengthen Portfolio
with steady rhythm
of science-based
new products
Expand Footprint
in key high-growth
emerging markets
Grow, shape, and further
penetrate the adult
nutrition market
Expand Operating
Margins to fund
investments in growth
Title © 2012 Abbott Laboratories 7
Page 7 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

8. Abbott Nutrition
Leading with Science
Title © 2012 Abbott Laboratories 8
Page 8 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Singapore
• Strong investment in R&D; part of our heritage
• Increasing R&D Productivity
– 5x increase in annual new product launches
– 10x increase in clinical trials & patent applications
• Expanding our footprint and capabilities
– New facilities in or near priority emerging markets
– Partnerships to leverage external expertise

9. Abbott Nutrition
Science-Based Benefit Platforms
Tolerance
Lean
Body Mass
Cognition
Metabolism
Title © 2012 Abbott Laboratories 9
Page 9 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Immunity
Inflammation
• Early Development
• Learning & Memory
• Sensitivity
• Comfort
• GI Health
• Resistance
• Allergies
• Caloric
• Density
• Epigentics
• Diabetes
• Muscle & Bone
• Recovery
• Inflammatory
Disease Processes

10. Pediatric Nutrition
Science-based, Differentiated Portfolio
MATERNAL INFANT UP-AGE SPECIALTY
Combination Prime Nutrition
Title © 2012 Abbott Laboratories 10
Page 10 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

11. Abbott Nutrition
Growth Strategies
Strengthen Portfolio
with steady rhythm
of science-based
new products
Expand Footprint
in key high-growth
emerging markets
Grow, shape, and further
penetrate the adult
nutrition market
Expand Operating
Margins to fund
investments in growth
Title © 2012 Abbott Laboratories 11
Page 11 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

12. Pediatric Nutrition
Focused on Key Priority Emerging Markets
China
India
Brazil
Russia
Vietnam
Mexico
Turkey
Title © 2012 Abbott Laboratories 12
Page 12 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

13. Abbott Nutrition
Growth Strategies
Strengthen Portfolio
with steady rhythm
of science-based
new products
Expand Footprint
in key high-growth
emerging markets
Grow, shape, and further
penetrate the adult
nutrition market
Expand Operating
Margins to fund
investments in growth
Title © 2012 Abbott Laboratories 13
Page 13 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

14. Adult Nutrition
Favorable Demographics
Population Age 50+ years old
(key markets; in millions)
China India United
States
2010 2050 2010 2050
Brazil Mexico Vietnam UK Indonesia Japan
% of Total Population
Source: United Nations, Department of Economic and Social Affairs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition.
Title © 2012 Abbott Laboratories 14
Page 14 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
(key markets)
22% 40%

15. Adult Nutrition
Innovation to meet local market and clinical needs
Category
Creation
Ensure
1973
Innovation
Global Expansion
Local Solutions
Title © 2012 Abbott Laboratories 15
Page 15 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Ensure
Today

16. Adult Nutrition
Broad Portfolio for Recovery and Healthy Aging
Most Sick &
Compromised
Title © 2012 Abbott Laboratories 16
Page 16 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Well and
Healthy Aging
Acute Care Hospital Recovery/LTC Disease-Specific Healthy Aging
• Diabetes
• Kidney Disease
• Oncology

17. Adult Nutrition
Lean Body Mass loss in Aging and Recovery
Average muscle-mass loss with age
Lean Body Mass loss in Bed Rest1
Change (Kg)
0
-0.5
-1.0
Title © 2012 Abbott Laboratories 17
Page 17 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Hospitalized Older Patients
~1 kg
(>2lbs)
More than 2 lbs in just 3 days
1Paddon-Jones, Abbott Nutrition Research Conference: Selected Summaries. The Role of Nutrition in Accretion, Retention and Recovery of Lean Body Mass, from 2009:9-14

18. Adult Nutrition
Potential to Improve Health Economic Outcomes
• HEOR Study “Impact of Oral Nutritional Supplementation on Hospital Outcomes”
• Published in American Journal of Managed Care
• 44 million hospital episodes across the US over 11 years
Length of Stay Episode Cost
Title © 2012 Abbott Laboratories 18
Page 18 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
30 Day
Readmission Rate
21% 21.6% 6.7%
Source: Philipson, T.J., et al., Impact of Oral Nutritional Supplementation on Hospital Outcomes. Am J Managed Care. 2013;19:(2): 121-128.

19. Abbott Nutrition
Growth Strategies
Strengthen Portfolio
with steady rhythm
of science-based
new products
Expand Footprint
in key high-growth
emerging markets
Grow, shape, and further
penetrate the adult
nutrition market
Expand Operating
Margins to fund
investments in growth
Title © 2012 Abbott Laboratories 19
Page 19 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories

20. Nutrition Operating Margin:
Targeting >700 basis points of expansion
13.3% of sales
>20% of sales
Title © 2012 Abbott Laboratories 20
Page 20 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Margin Improvement
Initiatives
Product Materials
& Packaging
Manufacturing
Processes
& Plant Locations
Supply Chain
& Distribution
Product & Market
Rationalization
Abbott Nutrition
Significantly Expand Operating Margin
15.7% of sales

21. Abbott Nutrition
Unprecedented Capacity Expansion
Meeting Demand and Enhancing Profitability
Tipp City, Ohio
Aseptic Liquid Facility
Gujarat, India
Powder Facility
Title © 2012 Abbott Laboratories 21
Page 21 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Jiaxing, China
Powder Facility

22. Abbott Nutrition
Delivering Against our Key Growth Drivers
Leadership
#1 US Pediatric
#1 Adult
#1 or 2
in 25 countries
Balanced
Portfolio
55% Pediatric
45% Adult
55% OUS
45% US
Innovation
80 product
launches
in 2012
Scientific
heritage
6 key benefit
platforms
Emerging
Markets
45% of Sales
Building
portfolio,
presence,
capabilities
Title © 2012 Abbott Laboratories 22
Page 22 © 2013 Abbott L©a 2b0o1ra3t oArbiebsott Laboratories
Margin
Expansion
+240 bps
in 2012
≥300 bps
in 2013
>20% operating
margin by 2015